Driehaus Capital Management »

Aktis Oncology shares owned by Driehaus Capital Management

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Driehaus Capital Management from 13F filings

Historical chart of Driehaus Capital Management investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Driehaus Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 150k 17.89

More positions owned by Driehaus Capital Management

TSMC Adr (TSM)
Praxis Precision Medicines I (PRAX)
Xenon Pharmaceuticals (XENE)
Crinetics Pharmaceuticals In (CRNX)
Planet Labs Pbc Com Cl A (PL)
Fabrinet (FN)
Apogee Therapeutics (APGE)
Lumentum Hldgs (LITE)
Curtiss-Wright (CW)
Credicorp (BAP)
Ftai Aviation (FTAI)
Edgewise Therapeutics (EWTX)
Guardant Health (GH)
Aeglea Biotherapeutics (SYRE)
InterDigital (IDCC)

View all positions for Driehaus Capital Management

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology